from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0068/-

LFCtreatmentdescriptionclass of inhibitor

0.718

Amikacinug/mL Amikacintranslation

1.201

Cap5-10ug/mL Capreomycintranslation

1.224

Rox10-50 ug/mL Roxithromycintranslation

0.272

SM2-5 ug/mL Streptomycintranslation

0.793

Tet5-10 ug/mL Tetracyclinetranslation

-0.858

Rif0.2-5ug/mL Rifampicintranscription

-0.572

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.196

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.014

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.735

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.631

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.546

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.551

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.602

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.132

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.076

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.051

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.960

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.426

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.245

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.305

KCN5-20 ug/mL Potassium cyaniderespiration

-0.332

NaN30.2-2 mM Sodium aziderespiration

-0.161

Nigericin50 uM Nigericinrespiration

-0.028

TRC10-150 ug/mL Triclosanrespiration

0.620

TRZ10-25 ug/mL Thioridazinerespiration

1.100

Valinomycin0.5-10 uM Valinomycinrespiration

0.307

ZnSO42 mM ZnSO4respiration

0.683

menadione6-10 ug/mL Menadionerespiration

-0.569

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.091

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.157

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.084

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.174

NRP_1Non-replicating persistence stage 1dosRassociated

-0.054

Amp0.2mg/mL AmpicillincellWall

0.015

Cephalexin20-100 ug/mL CephalexincellWall

0.213

Cerulenin0.32-5 ug/mL CerulenincellWall

0.104

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.225

EMB10-20 ug/mL EthambutolcellWall

0.091

Eta12-40 ug/mL EthionamidecellWall

-0.097

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.038

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.556

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.533

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.099

BZA0.12 mg/mL BenzamidearomaticAmides

-0.060

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.350

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.152

H2O24 mM hydrogen peroxideDNAdamaging

-0.065

Levo10 ug/mL LevofloxacinDNAdamaging

-0.031

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.437

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.093

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.421

UVUV-irradiationDNAdamaging

2.180

ARP41-4 ug/mL Antitubercular compound ARP4?

0.441

Antimycin12.5-50 ug/mL Antimycin A?

0.031

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.391

PA_110-50 ug/mL Antitubercular compound PA-1?

0.033

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.027

PA8240.2-2 ug/mL PA-824?

-1.264

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.783

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.303

Verapamil50 uM Verapamil?

0.185

mercaptoethanol2 mM 2-Mercaptoethanol?

0.131

methoxatin10-20 ug/mL Methoxatin?